News

Eli Lilly: New Orforglipron Data In Focus As Commercial Business Outperforms (NYSE:LLY)

1 Mins read

This article was written by

ONeil Trader is a former stockbroker turned full-time independent investor. He focuses on finding growth and biotech stocks with significant growth potential and calculates ideas in large part based on best risk-adjusted returns.

He leads the investing group Growth Stock Forum which features: a model portfolio of 15-20 names updated regularly, a top picks list of up to 10 stocks that are expected to perform well in the current calendar year, trading ideas that target both short-term and medium-term moves, and chat with community dialogue and for questions. Learn More.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This article reflects the author’s opinion and should not be regarded as a buy or sell recommendation or investment advice in any way.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

Trend Following’s Bond Problem | Seeking Alpha

1 Mins read
Jeff Malec Managing Director & Partner has spent 25+ years in the futures industry, from his days as a clerk in the…
News

Vulcan Value Partners Q1 2026 Letter (Mutual Fund:VVPSX)

19 Mins read
Portfolio Review Our results are detailed in the table below. As we have often said, we place no weight on short-term results,…
News

Zions Bancorporation, National Association (ZION) Q1 2026 Earnings Call Transcript

1 Mins read
Operator Greetings, and welcome to Zions Bancorp’s First Quarter Earnings Conference Call. [Operator Instructions]. Please note that this conference is being recorded….
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *